Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 2-(bromomethyl)-4-methoxy-, ethyl ester is a chemical compound derived from benzoic acid, which is a naturally occurring substance found in various plants and is commonly used as a food preservative. This specific derivative features a bromomethyl and a methoxy group, which confer unique reactivity and properties to the molecule. It is primarily used in organic synthesis and pharmaceutical manufacturing, playing a crucial role in the development and synthesis of various medications and pharmaceutical products.

56427-63-5

Post Buying Request

56427-63-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

56427-63-5 Usage

Uses

Used in Pharmaceutical Manufacturing:
Benzoic acid, 2-(bromomethyl)-4-methoxy-, ethyl ester is used as an intermediate in the synthesis of pharmaceuticals for its reactivity and ability to form specific chemical bonds that are essential in creating certain medications.
Used in Organic Synthesis:
In the field of organic chemistry, Benzoic acid, 2-(bromomethyl)-4-methoxy-, ethyl ester is utilized as a building block for the creation of more complex organic molecules. Its unique structure allows it to participate in various chemical reactions, contributing to the development of new chemical entities and materials.
Used in Drug Development:
Benzoic acid, 2-(bromomethyl)-4-methoxy-, ethyl ester's properties make it a valuable asset in the research and development of new drugs. Its reactivity and structural features can be leveraged to design and synthesize novel pharmaceutical agents with potential therapeutic applications.
Overall, Benzoic acid, 2-(bromomethyl)-4-methoxy-, ethyl ester is a versatile chemical intermediate that finds application across various industries, particularly in the pharmaceutical sector, where it contributes to the advancement of medicine and the development of innovative treatments.

Check Digit Verification of cas no

The CAS Registry Mumber 56427-63-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,4,2 and 7 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 56427-63:
(7*5)+(6*6)+(5*4)+(4*2)+(3*7)+(2*6)+(1*3)=135
135 % 10 = 5
So 56427-63-5 is a valid CAS Registry Number.

56427-63-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 2-(bromomethyl)-4-methoxybenzoate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:56427-63-5 SDS

56427-63-5Relevant academic research and scientific papers

Synthesis of benzothiophenones and naphthothiophenone as anticholinesterases

Jung

, p. 5325 - 5327 (2013/07/26)

Since AChE and BuChE belong to the same serine hydrolazes, we designed and synthesized compounds 1-6 as anticholinesterases and measured their inhibition poteucies on ChEs. 7-Methoxy-3H-benzo[c]thiophen-1-one 4, 4,6-dibromo-5,7- methoxy-3H-benzo[c]thiophe

ISOINDOLINE COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY AND OTHER USES

-

Page/Page column 69-70, (2009/05/29)

Disclosed is a compound of Formula (I) in which W and R1-R6 are defined herein. Also disclosed is a method of treating spinal muscular atrophy, as well as methods of using such compounds to increase SMN expression, increase EAAT2 expression, or increase the expression of a nucleic acid that encodes a translational stop codon introduced directly or indirectly by mutation or frameshift.

ISOINDOLONES WITH HIGH BINDING AFFINITY TO BETA-AMYLOID AGGREGATES AND FIBRILS, AND ITS USE AND PREPARATION METHOD

-

Page/Page column 25-26, (2009/05/30)

The present invention relates to isoindolone compounds having high binding affinity to beta-amyloid fibrils, thereby being useful for an early diagnosis of degenerative cerebral diseases including dementia, and prevention and treatment of such diseases, i

[18F]-labeled isoindol-1-one and isoindol-1,3-dione derivatives as potential PET imaging agents for detection of β-amyloid fibrils

Lee, Ji Hoon,Byeon, Seong Rim,Kim, YoungSoo,Lim, Soo Jeong,Oh, Seung Jun,Moon, Dae Hyuk,Yoo, Kyung Ho,Chung, Bong Young,Kim, Dong Jin

scheme or table, p. 5701 - 5704 (2009/07/18)

In this study a novel series of isoindol-1-one and isoindol-1,3-dione derivatives for β-amyloid-specific binding agents is described. Twelve compounds were synthesized and evaluated via a competitive binding assay with [125I]TZDM against β-amyl

Ferroelectric liquid crystals induced by dopants with axially chiral 2,2′-spirobiindan-1,1′-dione cores

Boulton, Christopher J.,Finden, Jeremy G.,Yuh, Eagranie,Sutherland, Jeffrey J.,Wand, Michael D.,Wu, Gang,Lemieux, Robert P.

, p. 13656 - 13665 (2007/10/03)

The axially chiral dopants (R)-5,5′-, 5,6′-, and 6,6′-diheptyloxy-2,2′-spirobiindan-1,1′-dione ((R)-2, -3, and -4) were synthesized in optically pure form, and their absolute configurations were assigned by the exciton chirality method using circular dich

6,11-dihydrodibenz[b,e]oxepin-acetic acids and derivatives

-

, (2008/06/13)

6,11-Dihydrodibenz[b,e]oxepin-acetic acids and derivatives having the general formula STR1 are prepared by multi-step sequences. X is C=O, CHCl, CHBr, CH2 or CHOR4 ; Y is alkyl or alkoxy of 1 to 4 carbon atoms, halogen or trifluoromethyl; n is 0, 1, 2 or 3; Z is COOR5, CH2 OR5, CONR25 or CONHOR5 ; and R1 -R5 are hydrogen or alkyl of 1 to 4 carbon atoms. These compounds and the physiologically tolerable salts thereof are useful as antiinflammatory and analgesic agents.

Method of treating dermal inflammations

-

, (2008/06/13)

A method of treating dermal inflammation by topically administering to a patient an effective amount of a 6,11-dihydrodibenz[b,e]oxepinalkanoic acid, physiologically tolerable salt thereof, derivative thereof, or diacid precursor thereof is described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 56427-63-5